|1.||Li, Hui: 3 articles (05/2015 - 12/2011)|
|2.||Li, Nian-Guang: 3 articles (01/2015 - 01/2012)|
|3.||Shi, Qianping: 3 articles (01/2015 - 01/2012)|
|4.||Tang, Hao: 3 articles (01/2015 - 01/2012)|
|5.||Tang, Yuping: 3 articles (01/2015 - 01/2012)|
|6.||Ling, Eng-Ang: 3 articles (01/2015 - 01/2014)|
|7.||Rangarajan, Parakalan: 3 articles (01/2015 - 01/2014)|
|8.||Wu, Chunyun: 3 articles (01/2015 - 01/2014)|
|9.||Yuan, Yun: 3 articles (01/2015 - 01/2014)|
|10.||Huang, Yong: 3 articles (07/2013 - 02/2011)|
|1.||Cardiovascular Diseases (Cardiovascular Disease)
01/01/2014 - "Scutellarin is a flavonoid which is widely used for the treatment of cardiovascular diseases. "
07/01/2011 - "Scutellarin (SG) is a bioactive flavonoid used to treat cardiovascular disease. "
02/01/2010 - "Scutellarin is a flavonoid extracted from a traditional Chinese herb, Erigeron breviscapus Hand Mazz, which has been broadly used in treating various cardiovascular diseases. "
08/01/2006 - "Scutellarin is widely used in treating various cardiovascular diseases. "
12/01/2009 - "Scutellarin is the major effective ingredient of breviscapine, which is widely used in the treatment of cardiovascular diseases and has a remarkable achievement. "
09/01/2011 - "To investigate the protective effects of scutellarin benzyl ester on neonatal rats' cardiomyocytes injured by ischemia and its anti-apoptosis mechanism. "
09/01/2011 - "In addition, each dose of scutellarin benzyl ester could significantly reduce the release of LDH from cardiomyocytes injured by ischemia (P<0.01). "
09/01/2011 - "After exposure to ischemic condition, the cell viability of the model group was degraded compared with that of the control group (P<0.01) and scutellarin benzyl ester (high and medium doses) could attenuate the loss of cell viability induced by ischemia (P<0.01 and P<0.05). "
09/01/2007 - "The results demonstrate that the protective effects of scutellarin on cardiovascular and cerebrovascular ischemia were better than its mixture, breviscapine, in rats."
09/01/2007 - "Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats."
09/01/2008 - "Therefore, our results suggest that scutellarin has anti-inflammation effect that may afford some protection against hyperglycemia-induced vascular inflammatory both in vitro and in vivo."
09/01/2008 - "In present study, we investigated the inhibition action of scutellarin on high glucose-induced vascular inflammation in human endothelial cells (ECV304 cells). "
07/01/2013 - "The neurotoxicity of β-amyloid peptide toward rat brain is associated with enhanced oxidative stress, inflammation and apoptosis, all of which can be attenuated by scutellarin."
11/01/2008 - "The promoting angiogenesis and anti-inflammation effect of scutellarin on polyglycolic acid scaffold of balb/c mice model."
09/01/2008 - "Scutellarin isolated from Erigeron multiradiatus inhibits high glucose-mediated vascular inflammation."
|4.||Brain Ischemia (Cerebral Ischemia)
01/01/2015 - "Scutellarin regulates microglia-mediated TNC1 astrocytic reaction and astrogliosis in cerebral ischemia in the adult rats."
01/01/2015 - "Scutellarin regulates the Notch pathway and affects the migration and morphological transformation of activated microglia in experimentally induced cerebral ischemia in rats and in activated BV-2 microglia."
01/01/2013 - "To investigate neuroprotective effects of scutellarin (Scu) in a rat model of cerebral ischemia with use of (18)F-fluorodeoxyglucose ((18)F-FDG) micro positron emission tomography (microPET). "
12/01/2005 - "To investigate the neuroprotective effect and mechanisms of scutellarin, a flavonoid extracted from Erigeron breviscapus Hand Mazz, against neuronal damage following cerebral ischemia/reperfusion. "
12/01/2005 - "Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion."
04/01/2015 - "Scutellarin attenuates endothelium-dependent aasodilation impairment induced by hypoxia reoxygenation, through regulating the PKG signaling pathway in rat coronary artery."
06/01/2011 - "The cells of the primary culture were assigned randomly to five groups: control group, hypoxia model group (acute hypoxic injury was induced by exposing cells to anoxic condition with 95%N₂ and 5%CO₂) and high, moderate and low dose of scutellarin benzyl ester groups (pretreated with 100, 50 and 25 μmol/L scutellarin benzyl ester before hypoxia) with 6 wells in each group. "
06/01/2011 - "To investigate the effects of scutellarin benzyl ester on the expressions of Bcl-2 and Bax in cardiomyocytes after acute injury of hypoxia. "
06/01/2011 - "[Effects of scutellarin benzyl ester on the expressions of Bcl-2 and Bax in cardiomyocytes injured by acute hypoxia]."
01/01/2015 - "Protective Effects of Scutellarin on Human Cardiac Microvascular Endothelial Cells against Hypoxia-Reoxygenation Injury and Its Possible Target-Related Proteins."
|1.||Calcium-Calmodulin-Dependent Protein Kinase Type 2
|4.||Proteins (Proteins, Gene)
|5.||Reactive Oxygen Species (Oxygen Radicals)
|6.||Amyloid (Amyloid Fibrils)
|7.||Apoptosis Inducing Factor
|8.||Monoamine Oxidase (MAO)
|1.||Surgical Instruments (Clip)
|2.||Heterologous Transplantation (Xenotransplantation)